Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
IER3 Antibody, DIF-2 Antibody, DIF2 Antibody, Gly96, mouse, homolog of Antibody, IEX1 Antibody, IEX-1L Antibody, Immediate early protein GLY96 Antibody, Immediate early response 3 Antibody, Immediately early gene X-1 Antibody, GLY96 Antibody, IEX-1 Antibody, Protein DIF-2 Antibody, Protein PRG1 Antibody, PRG1 Antibody, Anti-death protein Antibody
May play a role in the ERK signaling pathway by inhibiting the dephosphorylation of ERK by phosphatase PP2A-PPP2R5C holoenzyme. Acts also as an ERK downstream effector mediating survival. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.